ALSGD SpineGuard SA

0.0918USD0.0835 EUR · EPA-3.58%Mkt Cap: 8.89M USDP/E: —

SpineGuard SA provides designs, develops, and markets medical devices in the United States, Europe, Latin America, Asia Pacific, and the Middle East. The company offers PediGuard drilling instruments comprising straight,…

Key Statistics

Company
Market Cap8.89M USD
Enterprise Value9.66M USD
Revenue (TTM)3.39M USD
Gross Profit3.26M USD
Net Income (TTM)-2.27M USD
Revenue/Share0.04 USD
Last Price0.0918 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees9
CountryFR
SectorHealthcare
IndustryMedical Devices
ISINFR0011464452
Valuation
P/E (Trailing)—
P/E (Forward)-2.78
PEG—
EV/EBITDA-4.18
EV/Revenue2.85
P/S2.62
P/B1.82
EPS (TTM)-0.02 USD
EPS (Forward)-0.03 USD
52W Range
0.08248% of range0.1924
52W High0.1924 USD
52W Low0.0824 USD
Profitability
Gross Margin78.85%
Oper. Margin-67.84%
EBITDA Margin-68.18%
Profit Margin-55.03%
ROE-37.78%
ROA-24.64%
ROIC-31.89%
ROCE-25.94%
Growth
Revenue Growth-31.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.14M USD
CapEx (TTM)126.72K USD
FCF Margin-14.39%
FCF Yield-5.49%
Net Debt771.90K USD
Net Debt/EBITDA-0.33
Net Debt/FCF—
Balance Sheet
Debt/Equity0.27
Current Ratio1.12
Quick Ratio0.73
Book Value/Sh0.05 USD
Cash/Share0.0077 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.96.88M
Float—
Insiders2.84%
Institutions0.00%
Technical
SMA 500.0988 (-7.1%)
SMA 2000.1085 (-15.4%)
Beta0.62
S&P 52W Chg8.68%
Avg Vol (30d)252.98K
Avg Vol (10d)416.68K
Technical Indicators
RSI (14)36.7
MACD-0.0006
MACD Signal-0.0002
MACD Hist.-0.0004
BB Upper0.1028 USD
BB Middle0.0978 USD
BB Lower0.0927 USD
BB Width10.34%
ATR (14)0.0057 USD
Vol Ratio (20d)0.75x

About SpineGuard (EPA: ALSGD)

›

SpineGuard (EPA: ALSGD) is listed on Euronext Paris, where its shares trade in EUR. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 9 employees.

The shares were at 0.0835 EUR on 20 November 2026, down 38.5% over 52 weeks. Its 52-week range is 0.0750 EUR to 0.1750 EUR: the price is 52.3% below the high and 11.3% above the low.

Its market capitalisation is 8.09M EUR.

SpineGuard reports return on equity of -37.8%, an operating margin of -67.8% and revenue down 31.6% year over year.

Its debt exceeds its cash by 702.24K EUR, a debt-to-equity ratio of 0.27. Its Piotroski F-score is 5 out of 9, an average reading of its financial health.